Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Publications found: 28,272

Sort by:

Atopic Dermatitis (Atopic Eczema) (Dermatology) - Drugs In Development, 2021

US$ 2,500.00

Atopic Dermatitis (Atopic Eczema) (Dermatology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atopic Dermatitis - Drugs In De...

June 2021 847 pages

Atrial Fibrillation (Cardiovascular) - Drugs In Development, 2021

US$ 2,000.00

Atrial Fibrillation (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atrial Fibrillation (Cardiovascular) - Dru...

June 2021 148 pages

Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) - Drugs In Development, 2021

US$ 2,000.00

Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Attent...

June 2021 199 pages

Batten Disease (Central Nervous System) - Drugs In Development, 2021

US$ 2,000.00

Batten Disease (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Batten Disease (Central Nervous System)...

June 2021 103 pages

Bromodomain Containing Protein 2 - Drugs In Development, 2021

US$ 3,500.00

Bromodomain Containing Protein 2 - Drugs In Development, 2021 SUMMARY According to the recently published report 'Bromodomain Containing Protein 2 - Drugs In Development, 2021'; Bromodomain Containing...

June 2021 82 pages

Bromodomain Containing Protein 3 (RING3 Like Protein or BRD3) - Drugs In Development, 2021

US$ 3,500.00

Bromodomain Containing Protein 3 (RING3 Like Protein or BRD3) - Drugs In Development, 2021 SUMMARY Bromodomain Containing Protein 3 (RING3 Like Protein or BRD3) pipeline Target constitutes close to 10...

June 2021 80 pages

Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Drugs In Development, 2021

US$ 3,500.00

Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Drugs In Development, 2021 SUMMARY Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Bromodomain-containing protein 4 is a protein e...

June 2021 176 pages

Bromodomain Testis Specific Protein - Drugs In Development, 2021

US$ 3,500.00

Bromodomain Testis Specific Protein - Drugs In Development, 2021 SUMMARY Bromodomain Testis Specific Protein (Cancer/Testis Antigen 9 or RING3 Like Protein or BRDT) pipeline Target constitutes close t...

June 2021 69 pages

Burns (Dermatology) - Drugs In Development, 2021

US$ 2,000.00

Burns (Dermatology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Burns (Dermatology) - Drugs In Development, 2021, provides...

June 2021 142 pages

Calcitonin Gene Related Peptide Type 1 Receptor - Drugs In Development, 2021

US$ 3,500.00

Calcitonin Gene Related Peptide Type 1 Receptor - Drugs In Development, 2021 SUMMARY Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) pipeline Target const...

June 2021 85 pages

Caspase 7 - Drugs In Development, 2021

US$ 3,500.00

Caspase 7 - Drugs In Development, 2021 SUMMARY Caspase 7 (Apoptotic Protease Mch 3 or ICE Like Apoptotic Protease 3 or CMH 1 or CASP7 or EC 3.4.22.60) - Caspase-7 (CASP7) is a human protein encoded by...

June 2021 56 pages

Cell Division Protein FtsZ (ftsz) - Drugs In Development, 2021

US$ 3,500.00

Cell Division Protein FtsZ (ftsz) - Drugs In Development, 2021 SUMMARY Cell Division Protein FtsZ (ftsz) - FtsZ is a protein encoded by the ftsZ gene. It is essential cell division protein that forms...

June 2021 36 pages

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (Central Nervous System) - Drugs In Development, 2021

US$ 2,000.00

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline gui...

June 2021 96 pages

Coccidioidomycosis (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Coccidioidomycosis (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Coccidioidomycosis (Infectious Disease)...

June 2021 86 pages

Complex Regional Pain Syndrome (Central Nervous System) - Drugs In Development, 2021

US$ 2,000.00

Complex Regional Pain Syndrome (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Complex Regional Pain S...

June 2021 66 pages

Congestive Heart Failure (Heart Failure) (Cardiovascular) - Drugs In Development, 2021

US$ 2,500.00

Congestive Heart Failure (Heart Failure) (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Fail...

June 2021 760 pages

Contrast Induced Nephropathy (Genitourinary Disorders) - Drugs In Development, 2021

US$ 2,000.00

Contrast Induced Nephropathy (Genitourinary Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Contrast Induced Nephrop...

June 2021 46 pages

Crigler-Najjar Syndrome (Genitourinary Disorders) - Drugs In Development, 2021

US$ 2,000.00

Crigler-Najjar Syndrome (Genitourinary Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Crigler-Najjar Syndrome (Geni...

June 2021 41 pages

Cryptococcosis (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Cryptococcosis (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cryptococcosis (Infectious Disease) - Drugs...

June 2021 62 pages

Dementia (Central Nervous System) - Drugs In Development, 2021

US$ 2,500.00

Dementia (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dementia (Central Nervous System) - Drugs In...

June 2021 682 pages

Drug Addiction (Central Nervous System) - Drugs In Development, 2021

US$ 2,000.00

Drug Addiction (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction (Central Nervous System)...

June 2021 258 pages

Dystrophin (DMD) - Drugs In Development, 2021

US$ 3,500.00

Dystrophin (DMD) - Drugs In Development, 2021 SUMMARY According to the recently published report 'Dystrophin - Drugs In Development, 2021'; Dystrophin (DMD) pipeline Target constitutes close to 57 mol...

June 2021 161 pages

Encephalomyelitis (Central Nervous System) - Drugs In Development, 2021

US$ 2,000.00

Encephalomyelitis (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Encephalomyelitis (Central Nervous S...

June 2021 69 pages

Epilepsy (Central Nervous System) - Drugs In Development, 2021

US$ 2,500.00

Epilepsy (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epilepsy (Central Nervous System) - Drugs In...

June 2021 789 pages

Exportin 1 - Drugs In Development, 2021

US$ 3,500.00

Exportin 1 - Drugs In Development, 2021 SUMMARY Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) pipeline Target constitutes close to 10 molecules. Out of which approximately 10 mo...

June 2021 143 pages

Familial Adenomatous Polyposis (Genitourinary Disorders) - Drugs In Development, 2021

US$ 2,000.00

Familial Adenomatous Polyposis (Genitourinary Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Familial Adenomatous P...

June 2021 87 pages

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Drugs In Development, 2021

US$ 3,500.00

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Drugs In Development, 2021 SUMMARY Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Frataxin is a p...

June 2021 77 pages

Gonorrhea (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Gonorrhea (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gonorrhea (Infectious Disease) - Drugs In Develo...

June 2021 127 pages

Gorlin Syndrome (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Gorlin Syndrome (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gorlin Syndrome (Oncology) - Drugs In Development, 2...

June 2021 186 pages

Granulomatosis with Polyangiitis (Immunology) - Drugs In Development, 2021

US$ 2,000.00

Granulomatosis with Polyangiitis (Immunology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Granulomatosis with Polyangiitis...

June 2021 147 pages

Human Cytomegalovirus Envelope Glycoprotein B (gB) - Drugs In Development, 2021

US$ 3,500.00

Human Cytomegalovirus Envelope Glycoprotein B (gB) - Drugs In Development, 2021 SUMMARY Human Cytomegalovirus Envelope Glycoprotein B (gB) - Human Cytomegalovirus envelope glycoprotein B plays an impo...

June 2021 61 pages

Iduronate 2 Sulfatase - Drugs In Development, 2021

US$ 3,500.00

Iduronate 2 Sulfatase - Drugs In Development, 2021 SUMMARY According to the recently published report 'Iduronate 2 Sulfatase - Drugs In Development, 2021'; Iduronate 2 Sulfatase (Alpha L Iduronate Sul...

June 2021 75 pages

Leucine Rich Repeat Serine/Threonine Protein Kinase 2 - Drugs In Development, 2021

US$ 3,500.00

Leucine Rich Repeat Serine/Threonine Protein Kinase 2 - Drugs In Development, 2021 SUMMARY Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) pipeline Target cons...

June 2021 74 pages

Leukotriene A 4 Hydrolase - Drugs In Development, 2021

US$ 3,500.00

Leukotriene A 4 Hydrolase - Drugs In Development, 2021 SUMMARY Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) pipeline Target constitutes close to 6 mol...

June 2021 50 pages

Liver Cirrhosis (Gastrointestinal) - Drugs In Development, 2021

US$ 2,000.00

Liver Cirrhosis (Gastrointestinal) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Cirrhosis (Gastrointestinal) - Drugs I...

June 2021 178 pages

Meniere Disease (Ear Nose Throat Disorders) - Drugs In Development, 2021

US$ 2,000.00

Meniere Disease (Ear Nose Throat Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Meniere Disease (Ear Nose Throat Di...

June 2021 43 pages

Muscarinic Acetylcholine Receptor M2 (CHRM2) - Drugs In Development, 2021

US$ 3,500.00

Muscarinic Acetylcholine Receptor M2 (CHRM2) - Drugs In Development, 2021 SUMMARY Muscarinic Acetylcholine Receptor M2 (CHRM2) pipeline Target constitutes close to 10 molecules. The latest report Musc...

June 2021 86 pages

Muscarinic Acetylcholine Receptor M4 (CHRM4) - Drugs In Development, 2021

US$ 3,500.00

Muscarinic Acetylcholine Receptor M4 (CHRM4) - Drugs In Development, 2021 SUMMARY Muscarinic Acetylcholine Receptor M4 (CHRM4) - Muscarinic acetylcholine receptor M4 or cholinergic receptor muscarinic...

June 2021 96 pages

Myocardial Ischemia (Cardiovascular) - Drugs In Development, 2021

US$ 2,000.00

Myocardial Ischemia (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Ischemia (Cardiovascular) - Dru...

June 2021 96 pages

Myocarditis (Cardiovascular) - Drugs In Development, 2021

US$ 2,000.00

Myocarditis (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocarditis (Cardiovascular) - Drugs In Developmen...

June 2021 57 pages

N Sulphoglucosamine Sulphohydrolase - Drugs In Development, 2021

US$ 3,500.00

N Sulphoglucosamine Sulphohydrolase - Drugs In Development, 2021 SUMMARY According to the recently published report 'N Sulphoglucosamine Sulphohydrolase - Drugs In Development, 2021'; N Sulphoglucosam...

June 2021 60 pages

Nasal Polyps (Nasal Polyposis) (Ear Nose Throat Disorders) - Drugs In Development, 2021

US$ 2,000.00

Nasal Polyps (Nasal Polyposis) (Ear Nose Throat Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nasal Polyps (Nasal...

June 2021 95 pages

Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) - Drugs In Development, 2021

US$ 3,500.00

Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) - Drugs In Development, 2021 SUMMARY Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) - Neuronal acetylcholine receptor subunit beta-2 is...

June 2021 63 pages

Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) - Drugs In Development, 2021

US$ 3,500.00

Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) - Drugs In Development, 2021 SUMMARY According to the recently published report 'Neuropeptide Y Receptor Type 2 - Drugs In Development, 2021';...

June 2021 37 pages

Osteogenesis Imperfecta (Genitourinary Disorders) - Drugs In Development, 2021

US$ 2,000.00

Osteogenesis Imperfecta (Genitourinary Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteogenesis Imperfecta (Geni...

June 2021 90 pages

Osteomyelitis (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Osteomyelitis (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteomyelitis (Infectious Disease) - Drugs I...

June 2021 55 pages

Pressure Ulcers (Dermatology) - Drugs In Development, 2021

US$ 2,000.00

Pressure Ulcers (Dermatology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pressure Ulcers (Dermatology) - Drugs In Developm...

June 2021 30 pages

Primary Immune Deficiency (PID) (Genitourinary Disorders) - Drugs In Development, 2021

US$ 2,000.00

Primary Immune Deficiency (PID) (Genitourinary Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Primary Immune Defici...

June 2021 143 pages

Proto Oncogene Tyrosine Protein Kinase Src - Drugs In Development, 2021

US$ 3,500.00

Proto Oncogene Tyrosine Protein Kinase Src - Drugs In Development, 2021 SUMMARY Proto Oncogene Tyrosine Protein Kinase Src (Proto Oncogene c Src or pp60c src or SRC or EC 2.7.10.2) pipeline Target con...

June 2021 109 pages

Pruritus (Dermatology) - Drugs In Development, 2021

US$ 2,000.00

Pruritus (Dermatology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pruritus (Dermatology) - Drugs In Development, 2021, pro...

June 2021 221 pages

Filters

Clear all